Tatsis Ourania sold VRTX
May 31, 2024 · Form 4 insider transaction
Tatsis Ourania sold 2,250 shares of Vertex Pharmaceuticals Incorporated at $445.00 per share, a transaction worth $1.00M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,250
Price
$445.00
Total value
$1.00M
InsiderTatsis Ourania
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 31, 2024
Filing dateJune 3, 2024
Shares owned after51,273
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024.